How I manage sickle cell patients with high transcranial doppler results

Area of Science:

• Pediatric Hematology
• Neurology
• Medical Imaging

Background:

• Stroke is a severe complication in children with sickle cell anaemia (SCA).
• Transcranial Doppler (TCD) is a validated, non-invasive tool for assessing stroke risk.
• Current guidelines recommend TCD monitoring for stroke risk stratification in pediatric SCA patients.

Purpose of the Study:

• To outline an evidence-based algorithm for managing abnormal TCD velocities in children with SCA.
• To discuss the utility of TCD in primary stroke prevention and other clinical scenarios.
• To highlight the role of TCD in guiding therapeutic interventions for stroke risk reduction.

Main Methods:

• Review of randomized controlled trials demonstrating TCD efficacy in stroke risk stratification.
• Analysis of resource allocation for TCD monitoring programs.
• Discussion of alternative therapies like hydroxycarbamide and the need for frequent TCD follow-up.

Main Results:

• Chronic transfusion therapy is effective for stroke prevention based on TCD risk stratification.
• Hydroxycarbamide therapy can replace transfusions in select patients with careful TCD monitoring.
• TCD plays a crucial role in managing abnormal velocities and guiding treatment decisions.

Conclusions:

• TCD monitoring is essential for stroke risk assessment and prevention in children with SCA.
• An evidence-based algorithm can optimize the management of abnormal TCD findings.
• TCD has broader applications, including in Haemoglobin SC disease management.